The tumor-associated cells were largely derived from small intestine SFB-specific Th17 cells, and acquired Th1-like properties that were likely critical for enhancing mobilization and effector functions of tumor-infiltrating CD8+ T cells and other tumor-associated CD4+ T cells, thereby contributing to tumor control. The gene discussed is CD8A; the disease is neoplasm.